Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05916547
Status:
COMPLETED
Last Update Posted:
2024-07-11
First Post:
2023-06-15
Brief Title:
Safety and Efficacy of P-ESWL and ERCP
Sponsor:
Changhai Hospital
Organization:
Changhai Hospital
Study Overview
Official Title:
Safety and Efficacy of Extracorporeal Shock Wave Lithotripsy and Endoscopic Retrograde Cholangiopancreatography for Pancreatic Stones
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the types incidence and risk factors of adverse events after pancreatic extracorporeal shock wave lithotripsy P-ESWL and endoscopic retrograde cholangiopancreatography ERCP define the grading criteria of adverse events after P-ESWL and ERCP and analyze the efficacy of P-ESWL and ERCP which will provide evidence-based medical evidence to guide physicians clinical practice
Detailed Description:
Currently pancreatic extracorporeal shock wave lithotripsy P-ESWL and endoscopic retrograde cholangiopancreatography ERCP has become the preferred treatment for pancreatic duct stones Although some studies had confirmed the safety and efficacy of P-ESWL and ERCP the sample size were small and the follow-up period were short Therefore investigators designed this study with a large sample and a long follow-up period to clarify the efficacy and safety of P-ESWL and ERCP so as to guide clinical work standardize the diagnosis and treatment process of adverse events
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None